Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
Clinical trial NCT03267433 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03267433
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2027-01-31
- Enrollment
- 689
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.